載入...
A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase
BACKGROUND: Vitamin K antagonists (VKAs), such as warfarin, have remained the cornerstone of oral anticoagulation therapy in the prevention and treatment of thromboembolism for over half a century. They function by impairing the biosynthesis of vitamin K-dependent (VKD) clotting factors through the...
Na minha lista:
| 發表在: | J Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7925372/ https://ncbi.nlm.nih.gov/pubmed/33314621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15209 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|